Pharmaceutical compositions containing GBA1 and GCS dual control agents

TW202626636APending Publication Date: 2026-07-01ONO PHARMA CO LTD

0 Cites 0 Cited by

Patent Information

Application Number: TW114132865
Authority / Receiving Office: TW · TW
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-08-29
Filing Date: 2025-08-28
Publication Date: 2026-07-01

Application Information

Patent Timeline

29 Aug 2024

Priority

28 Aug 2025

Application

TW114132865

01 Jul 2026

Publication

TW202626636A

IPC: C07D417/14; A61K31/55; A61P25/00; A61P29/00; A61P35/00; C07D223/08; C07D403/12; C07D417/12

Inventors: 近藤隆史; 竹内淳

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

This invention provides a pharmaceutical composition containing a compound having dual-control activity against GBA1 and GCS in the prevention and / or treatment of diseases related to GBA1 and / or GCS. The compound represented by formula (I) of this invention, or a pharmaceutically permissible salt thereof, has dual-control activity against GBA1 and GCS. Therefore, a pharmaceutical composition containing the compound represented by formula (I) or a pharmaceutically permissible salt thereof can be used as a preventive and / or therapeutic agent for diseases related to GBA1 and / or GCS.

Need to check novelty before this filing date? Find Prior Art